EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Soft tissue sarcomas: new opportunity of treatment with PARP inhibitors?

Monica Mangoni, Mariangela Sottili, Giulia Salvatore, Domenico Campanacci, Guido Scoccianti, Giovanni Beltrami, Camilla Delli Paoli, Luca Dominici, Virginia Maragna, Emanuela Olmetto, Icro Meattini, Isacco Desideri und 3 weitere

La radiologia medica · 2019-04 · 124 (4) · 282-289

DOI: 10.1007/s11547-018-0877-4 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift La radiologia medica, online erschienen am 26.03.2018. Verfasst von Monica Mangoni und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical, Experimental and Clinical Sciences "Mario Serio", Section of Radiation Oncology, University of Florence, Largo Brambilla 3,…. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Istituto Toscano Tumori.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Poly(ADP-ribose) polymerases (PARP) are a large family of enzymes involved in several cellular processes, including DNA single-strand break repair via the base-excision repair pathway. PARP inhibitors exert antitumor activity by both catalytic PARP inhibition and PARP-DNA trapping, moreover PARP inhibition represents a potential synthetic lethal approach against cancers with specific DNA-repair defects. Soft tissue sarcoma (STSs) are a heterogeneous group of mesenchymal tumors with locally destructive growth, high risk of recurrence and distant metastasis. OBJECTIVES: The purpuse of this review is to provide an overview of the main preclinical and clinical data on use of PARPi in STSs and of effect and safety of combination of PARPi with irradiation. RESULTS: Due to numerous genomic alterations in STSs, the DNA damage response pathway can offer an interesting target for biologic therapy. Preclinical and clinical studies showed promising results, with the most robust evidences of PARPi efficacy obtained on Ewing sarcoma bearing EWS-FLI1 or EWS-ERG genomic fusions. The activity of PARP inhibitors resulted potentiated by chemotherapy and radiation. Although mechanisms of synergisms are not completely known, combination of radiation therapy and PARP inhibitors exerts antitumor effect by accumulation of unrepaired DNA damage, arrest in G2/M, activity both on oxic and hypoxic cells, reoxygenation by effect on vessels and promotion of senescence. Early trials have shown a good tolerance profile. CONCLUSIONS: The use of PARP inhibitors in advanced stage STSs, alone or combined in multimodal treatments, is of great interest and warrants further investigations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnimalsCombined Modality TherapyDNA DamageHumansPoly(ADP-ribose) Polymerase InhibitorsSarcoma

Stichwörter der Autor:innen

DNA damage response pathwayPoly(ADP-ribose) polymerases (PARP)Radiation therapySoft tissue sarcoma (STSs)

Substanzen

Poly(ADP-ribose) Polymerase Inhibitors

Autor:innen und Institutionen

  • Department of Biomedical, Experimental and Clinical Sciences "Mario Serio", Section of Radiation Oncology, University of Florence, Largo Brambilla 3, 50134, Florence, Italy. monica.mangoni@unifi.it.
  • ITT, Istituto Toscano Tumori, Via Taddeo Alderotti 26/N, 50139, Florence, Italy. monica.mangoni@unifi.it.
  • Department of Biomedical, Experimental and Clinical Sciences "Mario Serio", Section of Radiation Oncology, University of Florence, Largo Brambilla 3, 50134, Florence, Italy.
  • ITT, Istituto Toscano Tumori, Via Taddeo Alderotti 26/N, 50139, Florence, Italy.
  • Department of Orthopaedic Oncology, Azienda Ospedaliera Universitaria Careggi, Largo Brambilla 3, 50134, Florence, Italy.

Förderung

  • Istituto Toscano Tumori

Zitieren

APA

Mangoni, M., Sottili, M., Salvatore, G., Campanacci, D., Scoccianti, G., Beltrami, G., Delli Paoli, C., Dominici, L., Maragna, V., Olmetto, E., Meattini, I., Desideri, I., Bonomo, P., Greto, D., & Livi, L. (2019). Soft tissue sarcomas: new opportunity of treatment with PARP inhibitors?. La radiologia medica, 124(4), 282-289. https://doi.org/10.1007/s11547-018-0877-4

Vancouver

Mangoni M, Sottili M, Salvatore G, Campanacci D, Scoccianti G, Beltrami G, et al. Soft tissue sarcomas: new opportunity of treatment with PARP inhibitors?. La radiologia medica. 2019;124(4):282-289. doi:10.1007/s11547-018-0877-4

BibTeX
@article{Mangoni2019,
  author = {Mangoni, Monica and Sottili, Mariangela and Salvatore, Giulia and Campanacci, Domenico and Scoccianti, Guido and Beltrami, Giovanni and Delli Paoli, Camilla and Dominici, Luca and Maragna, Virginia and Olmetto, Emanuela and Meattini, Icro and Desideri, Isacco and Bonomo, Pierluigi and Greto, Daniela and Livi, Lorenzo},
  title = {Soft tissue sarcomas: new opportunity of treatment with PARP inhibitors?},
  journal = {La radiologia medica},
  year = {2019},
  volume = {124},
  number = {4},
  pages = {282--289},
  doi = {10.1007/s11547-018-0877-4}
}
Kostenlos starten →